BMAC – Biopharmaceutical Manufacturer's Advisory Council
An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.
Our Development Services Team performs laboratory work that enables our customers to create mammalian cell culture processes, used to produce novel therapeutic proteins. Our team of scientists comprises experts in cell culture, purification and analytical development. To provide more capacity for this work in Singapore, we have expanded our laboratory in Tuas alongside establishing a new laboratory at Science Park. The laboratories will contain the latest cutting-edge technologies including complex instrumentation, laboratory automation and novel process technologies.
Lonza Singapore’s Cell Gene Technologies (CGT) operates multiple purpose-built GMP-qualified production suites for the manufacture of Cell Therapy products designated for clinical trials and commercial
As the biopharmaceutical industry has evolved over the past 2 decades, Lonza has matched its evolution.